and obesity were observed to have negative synergistic effect over glucose metabolism. [8, 10] Further, it is detected that intermittent hypoxia leads to insulin resistance and beta-cell dysfunction. [10] OSA and metabolic syndrome (MS) are highlighted as syndrome Z which can increase the risk of cardiovascular disease [11] and insulin resistance. The possible mechanistic interactions between OSA, MS, and insulin resistance are highlighted in Figure 1 . It has been observed that in India, the prevalence of syndrome Z ranges from 4.5% in population-based study to 79% among patients in hospital-based study. [12, 13] The National Cholesterol Education Program Adult Treatment Panel III report gives the definition of MS in view of considering the five parameters that include hypertension, insulin resistance or glucose tolerance, low-serum high-density lipoprotein cholesterol, elevated serum triglyceride levels, and abdominal obesity. [14] The above five set variables provide for easy identification of MS. These pose a serious threat of atherosclerotic cardiovascular disease and need to be diagnosed at an early stage in order to prevent further complications. Therefore, increased awareness is the need of the hour in order to screen the patients for Syndrome Z and its further threatening outcomes. This study aimed at studying the patients diagnosed with OSA and its association with MS.
methodology
The study was conducted in a tertiary care service hospital from February 2017 to March 2018. A total of 95 patients underwent 32 channel polysomnography (Alice 5) and 58 patients met the Apnea-Hypopnea Index (AHI) criteria of OSA. However, eight patients who were hemodynamically unstable were excluded. The remaining 50 patients were taken up for further investigations. After a thorough polysomnography study, the patients diagnosed with OSA were followed up on outpatient department basis monthly. They were further evaluated with detailed history about their personal details, history of habits, symptoms, and treatment history. History regarding the quality of sleep was given due importance.
The patients were screened for any comorbid illness with hematological and biochemical parameters, including the metabolic markers such as body mass index (BMI), thyroid profile, lipid profile, and blood glucose profile. The data were scored manually as per the recommendations of the American Academy of Sleep Medicine. [15] The number of apnea and hypopnea occurring per hour of sleep is termed as AHI. AHI of 5 or more is suggestive of OSA, while a score of 5-14 suggests mild OSA, 15-30 is moderate OSA, and severe OSA has AHI more than 30 [16] [ Table 1 ]. Excessive daytime somnolence was assessed based on Epworth sleepiness scale (ESS). [17] Considering the time Figure 1 : Possible mechanistic links between obstructive sleep apnea, metabolic syndrome, and insulin resistance and feasibility, 50 patients diagnosed with OSA were investigated for the same and taken as the sample size for our descriptive study. Patients who were symptomatic but not meeting the AHI criteria and hemodynamically unstable were excluded from this study. The study was approved by the Institutional Ethics Committee and informed consent was obtained from the study participants.
Statistical analysis
Data were collected and analyzed using SPSS Inc. PASW Statistics for Windows, Version 18.0. Chicago: USA. All continuous variables were summarized in terms of mean ± standard variation and other categorical variables were calculated as percentage. Pearson's bivariate correlation method was used to find the association. P < 0.05 was considered statistically significant.
results

Baseline characteristics
Out of the total 50 studied OSA patients, 41 (82%) were male and 9 (18%) were female. The baseline characteristics are mentioned in Table 2 . Out of 50 patients analyzed in the study, 28 (56%) were obese having BMI of more than 27 kg/m 2 and 22 (44%) were found to be nonobese with BMI <27 kg/m 2 . Out of the 50 patients, 4 (8%), 17 (34%), and 29 (58%) were detected to be suffering from mild, moderate, and severe OSA, respectively. 60% of the study population had a positive history of regular and occasional use of alcohol, while 32% had positive history of smoking.
Based on the symptomatology, 88% had daytime sleepiness, 56% had frequent night awakenings, 28% with nonrestorative sleep, 35% with difficulty falling asleep, 56% had morning headache, 40% had nasal congestion, 2% with personality changes, 72% with history of snoring, and 14% with nocturia. Occasional episodes of breathing pause (16%) and choking, aspiration, gasping, and body movements were seen in 4% each, respectively [ Table 3 ]. On further examination, 56% had hypertension and 14% were hypothyroid, 68% had impaired glucose tolerance, and 54% had dyslipidemia [ Table 4 ].
Apnea-Hypopnea Index and its association with various clinical variables
Severity of AHI with BMI: Out of 28 obese patients, 22 (78.57%) had AHI >30. Of the 22 nonobese patients, 7 (31.81%) had AHI >30 [ Table 5 ]. AHI with smoking: 16 of the 50 patients studied were found to be smokers of which 11 (22%) had AHI >30 [ Table 5 ].
AHI with treatment history and comorbidities: 17 of the patients studied were on antihypertensives only, of which 12 had AHI >30. All the 4 patients on Oral hypoglycemic agents (OHAs), only had AHI >30. 11 of the 50 patients were on both OHAs and antihypertensive therapy, of these 4 had AHI >30. Two patients who were on other medications (1 for coronary artery disease and 1 for old cerebro Vascular accident (CVA)) had AHI >30. Seven of these 50 patients were coincidentally found to have hypothyroidism of which 2 had AHI <30 [ Table 5 ]. 31 patients were detected to have MS [as per the criteria in Table 1 ] out of which 27 (65% of all males) were males. Using Pearson's bivariate correlation method, a highly significant association (P = 0.01) was observed between AHI score and BMI value.
dIscussIon
In this study, a total of 50 patients (41 males and 9 females) were between the age group of 28 and 84 years who were diagnosed as OSA patients by standard polysomnography. They were studied for their clinical profile and were assessed for further relationship between OSA and MS. The mean age of the population was 42.5 years. The mean BMI, AHI, waist circumference, and neck circumference were 27.02 kg/m 2 , 33.49/h, 94.5 cm, and 39.7 cm, respectively. Our study revealed males and those people with higher neck circumference, BMI and who are aged above 40 years are found to have association with development of OSA. Similar findings were reported in a recent Indian study. [18] The common symptoms were excessive daytime sleepiness, snoring, frequent night awakenings, morning headache followed by others. Cases in this study had severe symptoms with many among them having associated comorbidities. This implies that a large number of patients of OSA with mild-to-moderate disease who are generally asymptomatic would remain undetected unless screened for the same. Impaired glucose tolerance (IGT)/dyslipidemia has shown an association with severity of OSA with MS; although this study was not designed to establish a cause-effect relationship.
Asian Indians have higher body fat, visceral fat and waist circumference, lower skeletal mass, thinner hips, higher rates of insulin resistance, diabetes, dyslipidemia, hypoadiponectinemia, and increased cardiovascular risk. [19, 20] In our study, 78.6% of the obese patients were found to have severe OSA, while only 31% of nonobese individuals had severe OSA. There has been an escalating rise in obesity and MS and its subsequent cardiovascular risk in South Asian population. [21] The obstructive sleep apnea syndrome (OSAS) affects 2%-4% of the adult population. It is a grossly underdiagnosed and undertreated condition. It is observed that OSA is also an important risk factor for the development of systemic hypertension, arrhythmias, [7] and cerebrovascular events. [22] The number of cardinal features of MS increases with increased severity of OSA. Out of the 50 OSA patients included in our study, 28 were known hypertensives. Apart from hypertension, 15 were known diabetic patients, 1 was an old case of CVA, and 3 had a history of ischemic heart disease. Several studies have reported high incidence of OSAS in patients of congestive heart failure. There was also significant association of OSA with MS leading to cardiovascular morbidity. [23] In our study, 29 (58%) patients were found to have severe OSA and 17 (34%) patients with moderate OSA. Similar observations were made by Peled et al. in their study, in which out of 98 patients 53 (54%) were found to have severe OSA and 27 (28%) had moderate OSA. [24] OSA is said to augment sympathetic nervous system activity and alter renin-angiotensin aldosterone system to cause BP derangements. A study by Sharma et al. concluded that in patients with moderate-to-severe obstructive sleep apneahypopnea syndrome, 3 months of continuous positive airway pressure (CPAP) lowers BP and partially reverses metabolic abnormalities. [25] 34 of our study patients were found to have impaired glucose tolerance. This is supported by various other cross-sectional studies that have reported a connecting link between the presence and severity of OSA and glucose tolerance, insulin resistance, and diabetes. [24, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Eventhough some studies have not reported positive findings in favor of this, [36] [37] [38] a study by Meslier et al. reports diabetes in one-third of suspected OSA patients, with increasing severity of OSA associated with IGT and insulin resistance, independently of age and BMI. [32] Obesity is strongly associated with MS and well-known risk factor for OSA. Now with increasing epidemic of obesity, the prevalence of OSA among adults is is further on the rise. In our study, 32% patients had BMI <25, 64% had BMI ranging from 25 to 29.9 and 4% had BMI of 30 and above. Our study showed significant association between AHI score and BMI value with a P = 0.043 (P < 0.05) and was depicted in Figure 2 . The shared relationship of OSA and MS with obesity should be taken into account because it is contributing airway narrowing during sleep. Obesity, especially central obesity, is a significant risk factor which is linked to increased leptin production further leading to insulin resistance and increased development of OSA. Hence, central obesity significantly causes upper airway functional abnormality as compared to peripheral obesity with raised fat deposition around the neck. [39] [40] [41] [42] There are also other studies which have shown that 3% reduction in AHI with every percent of weight reduction in the individual. [8, 43] Some studies have shown that OSA is associated with carotid intimal thickening, increased levels of a variety of oxidants such as C-reactive protein, interleukin-6, tumor necrosis factor-α, and pentraxin including oxidized low-density lipoprotein which are thought to play a key role in promoting atherosclerosis. [44, 45] In our study, 54% of the patients were found to have dyslipidemia and 14% patients were found to have hypothyroidism who showed increased propensity toward development of MS, similar observations were made by other workers. [46] [47] [48] The salient finding in our study revealed MS in 31 (62%) patients with coexistence of OSA. Similar findings were reported by Parish et al. [49] 
Limitation
The study results had certain limitations, as it was done in a single hospital. Hence, results of the study cannot be applied to the general population. Second, this study had a small sample size.
conclusIon
The relationship between OSA and MS still remains controversial despite substantial evidence from both clinical and population studies suggesting their link. CPAP which still remains the mainstay of OSA management, also forms the backbone of various research works trying to establish a link between the two conditions. However, in a resource-limited setting like India, the paucity of health-care facilities with polysomnography equipment and CPAP machine, pose a major hurdle to diagnosis, evaluation, and management of OSA, thus further hindering the researchers. Identification of syndrome Z may bring out opportunities to interrupt pathophysiology of OSA and prevent manifestations of MS.
